3-V Biosciences Announces Closing of $28.5M Financing Round
December 30, 2014 05:30 ET
|
3-V Biosciences
MENLO PARK, CA--(Marketwired - Dec 30, 2014) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious...
3-V Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference
December 02, 2014 05:30 ET
|
3-V Biosciences
MENLO PARK, CA--(Marketwired - Dec 2, 2014) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious...